KLRK1 and neoplasm: However, soluble NKG2D ligands generated by a disintegrin and metalloproteinase 10 (ADAM10), ADAM17, and matrix metalloproteinase 14 (MMP14), can promote NKG2D down-regulation, impairing NK cell-effector functions and facilitating tumor immune escape (54, 55).